Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jacqueline K. Dulworth"'
Publikováno v:
The Journal of pharmacy and pharmacology. 51(11)
The purpose of this work was to determine any effects the presence of sodium carboxymethyl starch may have on the antimicrobial activity of vancomycin given a previously described interaction between vancomycin and sodium carboxymethyl starch. In par
Publikováno v:
Chemotherapy. 43(4)
Compound MDL 62,879 (GE2270 A) is a thiazolyl peptide antibiotic that appears to inhibit aminoacyl-tRNA binding to elongation factor Tu. In the present study, it was shown that MDL 62,879 broth microdilution MIC values were generally 2-4 doubling dil
Autor:
Jacquelyn A. Smithers, Henrik K. Kulmala, Stephen J. Ruberg, Charles E. Halstenson, Michael T. Kenny, Jacqueline K. Dulworth, Bruce E. Shapiro, Eric W. Lewis, William F. Keane, Gary A. Thompson
Publikováno v:
Biopharmaceuticsdrug disposition. 13(8)
The pharmacokinetics of teicoplanin were investigated in 13 subjects with various degrees of renal impairment using a randomized two-period crossover design; 11 subjects completed both periods. Doses of 3 and 30 mg kg-1 were administered as single do
Autor:
Jacqueline K. Dulworth, Kelly K. Antony, Marcia B. Brackman, Gary A. Thompson, Lianng Yuh, Mark G. Eller, Ron Kuzma, Michael T. Kenny, Eric W. Lewis
Publikováno v:
Journal of pharmaceutical sciences. 80(6)
Pharmacokinetics, bioavailability, and local tolerance (at the site of intramuscular administration) of a new formulation of teicoplanin (400 mg/3 mL) were investigated in 24 normal, healthy, male volunteers. A single dose of 6 mg/kg was administered
Publikováno v:
Diagnostic microbiology and infectious disease. 14(1)
In this study, the in vitro activity of teicoplanin and vancomycin was directly compared against 503 Gram-positive cocci isolated during the U.S. teicoplanin clinical trials. Both antibiotics were equally active against oxacillin-sensitive Staphyloco
Autor:
Steven L. Roberds, Michael T. Kenny, Michael C. Graham, Harry L. Torney, Wen-Dar Cheng, Jacqueline K. Dulworth
Publikováno v:
International Journal of Immunopharmacology. 10:639-649
At physiologically relevant concentrations an antiviral compound should not perturb the host's ability to mount an immune response against the infecting virus or some other opportunistic pathogen. The purpose of this study was to evaluate the immunom
Publikováno v:
Antiviral research. 6(6)
Fifteen p-benzoylphenoxypyridines were initially evaluated for their in vitro activity against rhinoviruses (RV) 1A, 2 and 64 and coxsackie virus (Cox) A21 and for their oral prophylactic and therapeutic activity in Swiss albino mice lethally challen
Publikováno v:
Antiviral Research
The purpose of this study was to probe the antirhinovirus (RV) mechanism of action of MDL 20,610. Evaluation of the compound's effects on RV RNA synthesis, uncoating of neutral red-sensitized RV, plasma membrane penetration by RV, stabilization of RV
Autor:
Lowell D. Markley, Christopher T. Goralski, Wood Steven Glen, Anna P. Vinogradoff, David L. Steward, Howard Johnston, Yulan C. Tong, Jacqueline K. Dulworth, Thomas M. Bargar
Publikováno v:
Journal of medicinal chemistry. 29(3)
Phenoxybenzenes and phenoxypyridines were prepared and tested for the effect of substituents on antipicornavirus activity. The most active compound, 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (8), demonstrated broad-spectrum antipicornavirus activit
Autor:
Jacqueline K. Dulworth, Renee Massad, John K. Daniel, Michael T. Kenny, Roger N. Sargent, T. M. Bargar, Thomas Michael Wilson
Publikováno v:
Journal of medicinal chemistry. 29(9)
A general synthesis to the title compounds 1, substituted in the 6-position and on the phenyl ring, is outlined. Eighteen analogues were compared with respect to in vitro activity against rhinovirus types 1A, 9, and 64. Compounds 1c and 1h, the 6-bro